Run time: 301m

  0       0

2018 Annual Meeting On-Demand


2018 AM On-Demand: Program FR1-02-SS-2018: Cellular Therapies in Trauma and Critical Care


Oct 18, 2018 8:00am ‐ Oct 18, 2018 5:00pm

Expiration Date: Dec 31, 2020


Credits: None available.

Description

This program is available until December 31, 2020.

Program Chair: Shibani Pati, MD, PhD

Learning Objectives:

  • Describe the therapeutic potential of cellular therapies in trauma and critical care applications
  • Discuss the production and availability of CT products for trials and beyond and debate the challenges associated with the manufacture of these products
  • Identify current clinical trials, design and lessons learned from past trials for cellular therapies in trauma and critical care settings

Description: This one day workshop will focus on the emerging role of cellular therapies in the treatment of trauma and critical care conditions. Novel products and their applications as well as cell manufacturing, regulatory challenges and production needs will be addressed. The discussion will align the needs of those serving in the critical care and trauma field with those programs and facilities providing the product. A discussion of current clinical trials and lessons learned from designing these trials will also be presented. This workshop has been developed in collaboration with the Cellular Therapies in Trauma and Critical Care Conference (CTTACC) faculty.

Please note: Dr. Anthony Atala, Dr. Michael Matthay and Pamela Robey did not consent to presentation capturing and being recorded; therefore, their presentations are not included in the on-demand presentation.

Speaker(s):

Disclosures

  • Kenneth Bertram :

    Wake Forest Baptist Medical Center: Full-time/Part-time Employee  |  Tunnell Govt Services/MTEC: Consultant  |  The Conafay Group: Consultant  |  BioBridge Global: Consultant  |  KaloCyte: Consultant  |  Cellphire: Consultant  |  Critical Innovations: Consultant  |  McAllister and Quinn: Consultant  |  Martin, Blanck & Associates: Consultant

  • Michael Matthay, MD :

    Bayer Pharmaceuticals: Grant/Research Support (Secondary Investigators need not disclose)  |  CS Behring: Consultant

  • Robert Mays, PhD :

    Athersys, Inc.: Stock Shareholder (self-managed)  |  Athersys, Inc.: Full-time/Part-time Employee  |  Athersys, Inc.: Intellectual Property

  • Anthony Atala, MD :

    Nothing to Disclose

  • Becky Cap, MBA :

    Nothing to Disclose

  • David McKenna, MD :

    Nothing to Disclose

  • David Stroncek, MD :

    Nothing to Disclose

  • Martin Schreiber, MD :

    Nothing to Disclose

  • Naynesh Kamani, MD :

    Nothing to Disclose

  • Pamela Robey :

    Nothing to Disclose

  • Shibani Pati, MD, PhD :

    Nothing to Disclose

  • John Holcomb, MD :

    Prytime Medical: Full-time/Part-time Employee  |  Decisio Health: Stock Shareholder (self-managed)  |  Terumo BCT: Adv. Board

Credits

  • 5.00 - General Continuing Education (GEN)
  • 5.00 - Florida Lab Personnel (FLP)
  • 5.00 - California Nurse (CN)
  • 5.00 - California Lab Personnel (CLP)

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content